A clear glass protein ribbon sculpture on an acrylic block, beside a row of thin glass peaks like a mass spectrum.

Diagnostic menu


Advanced Proteomics

Explore protein-associated ageing signatures, biological pathways and personalised health insights.

Non-invasive cheek swab, collected at home or in a clinic.

Video

Watch the video

The video plays from YouTube. Nothing is loaded from YouTube until you press play.

  • Buccal swabNon-invasive collection
  • 7,496Protein groups in the curated library
  • 508 proteinsUsed in the ProteoAge model

Overview

Beyond a single biological age number

A non-invasive cheek-swab assessment combining high-resolution proteomics with computational models of ageing and functional protein patterns.

ProteoAge estimates age from a model of 508 proteins. The Index of Aging offers a separate model-based ageing indicator. Together with inferred Hallmarks of Aging contributions, these outputs offer complementary perspectives on ageing-associated molecular patterns—not a direct measurement of the rate of whole-body ageing.

What is measured

What the assessment explores

  • Model-derived estimates contextualised against chronological age.
  • Protein patterns mapped to genomic stability, epigenetic regulation, proteostasis, nutrient sensing, mitochondrial function, cellular senescence, inflammation, intercellular communication, macroautophagy and other processes.
  • Protein-associated nutrition and activity profiles, comparisons with questionnaire responses, and individualised food, exercise and supplement suggestions.
  • Exploratory signatures related to energy metabolism, nutrient handling, recovery and other physiological functions.

Inside the report

What the report shows

Five connected views

Ageing
22ProteoAge, years
0.8Index of Aging
Nutrition66Good
Sport58Good
Hallmarks−7.4Net ageing contribution, years · Excellent
Biomarkers
  • Excellent 15
  • Good 1
  • Optimisable 5
Illustrative dashboard. The values are example data from a sample report, not expected results for an individual.

ProteoAge and the Index of Aging

Calendar age 2822ProteoAge, years1838

−6.2years, model-derived difference from calendar age

0 · slower ageingfaster ageing · 2

Index of Aging 0.8 · Excellent

ProteoAge is trained on chronological age using 508 proteins. The report compares its estimate with calendar age and shows the model-derived difference. Example values.

Hallmarks of Aging: top 3 and bottom 3

Inflammation: −1.94 yearsInflammation−1.94Intercellular communication: −1.40 yearsIntercellular communication−1.40Nutrient sensing: −1.36 yearsNutrient sensing−1.36Microbiome: +0.16 yearsMicrobiome+0.16Macroautophagy: +0.38 yearsMacroautophagy+0.38Telomere length: +0.54 yearsTelomere length+0.54← protective (slows ageing)accelerating →
The Index of Aging and the Hallmarks of Aging give complementary views. Contributions labelled in years are model outputs and should not be read as years of life gained or lost. Example values.

Functional protein profiles

  • Nutrient profiles
    Vitamin A turnoverThe cycle of vitamin A
    Excellent
  • Vitamin E turnoverVitamin E usage in the body
    Excellent
  • Vitamin D turnoverUtilisation for bone, immune function and metabolism
    Excellent
  • Zinc turnoverZinc handling for immune function and healing
    Optimisable
  • Structural & organ health
    Renal efficiencyRemoving waste products
    Excellent
  • Connective tissue healthTissue resilience
    Excellent
  • Inflammatory response
    Inflammatory response (CRP-related)Acute inflammatory activity
    Excellent
Vitamin A, E and D turnover and zinc-related profiles are protein-based interpretations, not measurements of serum vitamin or zinc concentrations. Renal efficiency, connective tissue and CRP-related profiles do not replace renal function tests, clinical assessment or serum CRP testing. Example values.

What you get

From protein data to a plan you can act on

    • ProteoAge, a model-derived protein age compared with your calendar age
    • Your Index of Aging and Hallmarks of Aging profile
    • Nutrition and sport profiles
    • Functional protein profiles with clear status categories
    • Food, activity and supplement suggestions to review with a professional
    • A functional layer next to genetics, epigenetics, metabolomics and routine biomarkers
    • Hallmark-level contributions to help prioritise follow-up
    • A proteomic baseline for exploring change over time
    • Non-invasive collection, at home or in clinic
    • Reported test-retest repeatability for relative biological age

How it works

Simple collection, sophisticated analysis

  1. 01Collect a buccal swab at home or in clinic.
  2. 02The sample is returned according to the kit instructions.
  3. 03High-resolution Orbitrap mass spectrometry with data-independent acquisition supports protein profiling. The supplier reports a curated spectral library of 7,496 protein groups; coverage does not imply every group is quantified in every sample.
  4. 04A personalised proteomic report with explanations and recommendations.

Method and evidence

Evidence and responsible interpretation

  • Epigenetic assays characterise DNA methylation patterns; proteomics examines protein abundance patterns, which may reflect more proximal functional responses and exposures. Neither modality alone measures all hallmarks directly. The two should be interpreted as complementary, not interchangeable.
  • Supplier-reported baseline sample correlation: 0.84 in more than 500 participants. Relative biological age test–retest ICC: 0.905 (95% CI 0.776–0.961) in 20 stable controls approximately one month apart. These figures do not establish disease prediction, individual minimum detectable change or clinical utility.
  • Hallmark labels are algorithmically inferred from protein patterns. The test does not directly measure telomere length, DNA methylation, gut microbiome composition, blood nutrient concentrations or clinical inflammatory markers.
  • Reference samples run across plates and batches. On raw, non-normalised data the median protein-level CV is 30.4%, and housekeeping proteins range from 21.4% to 29.2%. Normalisation and batch correction then reduce technical variation. Reprocessing the same raw data gives 99% overlap in the selected fragments.

Repeatability of relative biological age

2020303040405050same result both timesFirst 37.9 · second 45.6 yearsFirst 47.8 · second 45.7 yearsFirst 45.9 · second 45 yearsFirst 51.8 · second 42.3 yearsFirst 41 · second 37.5 yearsFirst 39.4 · second 36.7 yearsFirst 38.4 · second 36.6 yearsFirst 35.2 · second 35.5 yearsFirst 36.4 · second 31.9 yearsFirst 33.2 · second 30.7 yearsFirst 24.5 · second 29.5 yearsFirst 22.6 · second 24.5 yearsFirst 30.8 · second 24.6 yearsFirst 23.3 · second 24.1 yearsFirst 19.9 · second 23.5 yearsFirst 19.2 · second 22.3 yearsFirst 21.8 · second 22.3 yearsFirst 22.1 · second 18.6 yearsFirst 29.9 · second 32 yearsFirst 29.6 · second 31.3 yearsICC 0.90595% CI 0.776–0.961 · n = 20Relative biological age, first sample (years)Second sample, about one month later
Twenty stable controls, sampled about one month apart. Points redrawn from the technical data. Repeatability supports consistency within this study; it does not establish disease prediction, intervention efficacy or an individual threshold for meaningful change.

Collection and analytical controls

  • 0.84Correlation between two baseline samples, more than 500 participants
  • 30.4%Median protein-level CV across reference samples, raw and uncorrected
  • 21–29%CV of housekeeping proteins across reference samples, raw
  • 99%Overlap in selected fragments when the same raw data is processed twice
From the technical data. These analytical measures do not establish clinical efficacy or an individual threshold for meaningful change.

Clinical value

Where it adds value in clinical practice

Consider as an adjunct when building a multi-omics baseline, discussing modifiable lifestyle factors, or following exploratory molecular patterns over time. Interpret alongside history, physical assessment, validated clinical biomarkers and patient priorities. Changes in inferred scores do not establish treatment efficacy or improved clinical outcomes.

  1. 01Establish the proteomic profile before anything changes.
  2. 02Read it with clinical history, routine testing and other omics.
  3. 03Interpret change against sampling conditions, analytical variation and biological variability.

Measure → Intervene → Re-measure → Verify

White-label opportunity

Your programme. Your brand. Our infrastructure.

Advanced Proteomics can be integrated into healthcare, longevity and preventive-health programmes as a branded or co-branded testing pathway, without building the laboratory infrastructure behind it.

  • Branded test kits and packaging
  • Integration into existing clinic or longevity programmes
  • Remote sample collection
  • Laboratory analysis
  • A patient-facing experience in your name
  • Results delivered into your preferred reporting environment
  • Repeat testing and longitudinal programmes
  • Sample collection at home, outside the clinic.
  • A protein-based ageing and lifestyle layer, without a blood draw.
  • Repeat testing to follow change over time.

Limitations

A model-derived view, not a diagnosis

Pathway scores are computational inferences, not direct measurements of the named processes. A microbiome-associated proteomic score is not a stool microbiome analysis; a telomere-associated score is not a telomere-length assay. Similarly, inflammatory or nutritional signatures do not diagnose inflammation or nutrient deficiencies. Personalised macro targets and supplement suggestions require clinical and dietary suitability review.

For informational and wellness use; not a standalone diagnostic test. All recommendations require qualified professional review. Availability and regulatory status vary by market.

Download fact sheet (PDF)Back to the diagnostic menu

Contact

Bring proteomics into your longevity programme

Contact BioAge Diagnostics to discuss clinic implementation, patient suitability, interpretation and access to a sample report.

Book an introductory meeting · Step 1 of 2

Who are we talking to?

Choose the one closest to you, so the right person from our team takes the meeting.